Related Experiment Video
Updated: Apr 7, 2026

Murine Kidney Transplant Technique
Published on: October 20, 2015
Pediatric transplantation: preventing thrombosis
1Haematology Service, Division of Medicine, Lady Cilento Children's Hospital, Brisbane, Qld, Australia.
Insights
Thrombosis prevention in pediatric transplant recipients is crucial for graft survival and quality of life. This review highlights the need for more pediatric-specific data on thrombosis risk and preventative strategies.
Area of Science:
- Transplantation Medicine
- Pediatric Hematology/Oncology
- Vascular Biology
Background:
- Advances in transplantation have improved patient outcomes.
- Thrombosis remains a significant complication impacting graft survival and quality of life.
- There is a lack of pediatric-specific data on thrombosis incidence and prevention.
Purpose of the Study:
- To review current practices for preventing thrombosis in transplant recipients.
- To focus on pediatric-specific risk factors, pathophysiology, and antithrombotic regimens.
- To identify gaps in knowledge and guide future treatment algorithms.
Main Methods:
- Systematic review of existing literature.
- Analysis of risk factors and pathophysiology of thrombosis in transplant patients.
- Evaluation of current antithrombotic strategies and their efficacy.
Main Results:
- Improved transplant outcomes necessitate better thrombosis management.
- Pediatric transplant recipients present unique challenges in thrombosis prevention.
- Current evidence on pediatric thrombosis prevention is limited.
Conclusions:
- Further research is needed to establish evidence-based guidelines for pediatric thrombosis prevention.
- Risk stratification and tailored antithrombotic strategies are essential.
- Collaboration is key to improving outcomes for pediatric transplant recipients.
Abstract:
Due to progressive advances in surgical techniques, immunosuppressive therapies, and supportive care, outcomes from both solid organ transplantation and hematopoietic stem cell transplantation continue to improve. Thrombosis remains a challenging management issue in this context, with implications for both graft survival and long-term quality of life. Unfortunately, there remains a general paucity of pediatric-specific data regarding thrombosis incidence, risk stratification, and the safety or efficacy of preventative strategies with which to guide treatment algorithms. This review summarizes the available evidence and rationale underlying the spectrum of current practices aimed at preventing thrombosis in the transplant recipient, with a particular focus on risk factors, pathophysiology, and described antithrombotic regimens.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management

